Inogen, Inc. (INGN)

Market Cap	192.07M
Revenue (ttm)	335.71M
Net Income (ttm)	-35.89M
Shares Out	26.53M
EPS (ttm)	-1.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	259,056
Open	7.47
Previous Close	7.37
Day's Range	7.11 - 7.47
52-Week Range	6.14 - 13.33
Beta	1.16
Analysts	Hold
Price Target	7.00 (-3.31%)
Earnings Date	May 6, 2025

About INGN

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related a...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 14, 2014
• Employees: 766
• Stock Exchange: NASDAQ
• Ticker Symbol: INGN
• Website: https://provider.inogen.com/en

Financial Performance

In 2024, Inogen's revenue was $335.71 million, an increase of 6.35% compared to the previous year's $315.66 million. Losses were -$35.89 million, -64.97% less than in 2023.

Analyst Forecast

According to 2 analysts, the average rating for INGN stock is "Hold." The 12-month stock price forecast is $7.0, which is a decrease of -3.31% from the latest price.

Price Target

$7.0

(-3.31% downside)

Analyst Consensus: Hold